Doctor profile · Federal record
Dr. Cayla Mays, NP
Nurse Practitioner · Muncie, IN
- NPI 1255099503
- Accepts Medicare
- 5 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 7 locations .
- Primary practice
-
1107 S Tillotson Ave
Muncie, IN 473044517
(765) 717-5399 - Additional location
-
1007 N 16Th St
New Castle, IN 473624320
fax (855) 792-0451 - Additional location
-
2451 Intelliplex Dr Ste 250
Shelbyville, IN 461768581 - Additional location
-
2705 S Berkley RD Ste 4D
Kokomo, IN 469028007 - Additional location
-
330 N Wabash Ave Ste 470
Marion, IN 469522685 - Additional location
-
813 N Lincoln St
Greensburg, IN 472401330
(756) 717-5399 - Additional location
-
900 Sim Hodgin Pkwy
Richmond, IN 473741932
Show 4 more locations
Credentials & registration
- NPI registered
- December 2021 — 5 yrs on file
- Profile last updated
- February 12, 2025
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Indiana #71011908A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1255099503. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
69,572
Distinct HCPCS
10
Medicare allowed
$1,111,378
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 38,000 | 31 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,376 | 45 | $41 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 13,600 | 26 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,192 | 14 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 785 | 362 | $100 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 258 | 72 | $48 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 189 | 31 | $56 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 161 | 126 | $5 | |
36415 |
Insertion of needle into vein for collection of blood sample | 157 | 123 | $8 | |
85651 |
Red blood cell sedimentation rate, to detect inflammation, non-automated | 155 | 122 | $4 |
In context: peer comparison
Among 11 peers in Muncie Nurse Practitioner, average services per provider: 883. This provider delivers 79× the peer median.Open Payments
Industry payments received
All-time total
$1,745
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 27 | $339.77 | |
| Janssen Biotech, INC. | 11 | $337.12 | |
| Amgen INC. | 14 | $199.08 | |
| Pfizer INC. | 15 | $135.53 | |
| Ucb, INC. | 12 | $134.87 | |
| Novartis Pharmaceuticals Corporation | 9 | $131.74 | |
| AstraZeneca Pharmaceuticals Lp | 5 | $93.51 | |
| Mallinckrodt Hospital Products INC. | 5 | $89.54 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $68.44 | |
| Lilly USA, LLC | 3 | $52.67 | |
| Ani Pharmaceuticals, INC. | 2 | $51.20 | |
| GlaxoSmithKline, LLC. | 2 | $31.44 | |
| Organon LLC | 1 | $25.95 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $19.20 | |
| Alexion Pharmaceuticals, INC. | 1 | $18.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,654
Patients
999
Total drug cost
$1,915,243
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 831 | 225 | $48,089 |
| Methotrexate (Methotrexate Sodium) | Brand | 585 | 154 | $15,439 |
| Prednisone | Generic | 538 | 154 | $3,890 |
| Leflunomide | Generic | 387 | 117 | $30,177 |
| Gabapentin | Generic | 254 | 56 | $4,311 |
| Meloxicam | Generic | 153 | 44 | $642 |
| Methylprednisolone | Generic | 133 | 82 | $1,137 |
| Tizanidine Hcl | Generic | 128 | 44 | $1,738 |
| Humira(Cf) Pen (Adalimumab) | Brand | 114 | 15 | $884,766 |
| Sulfasalazine | Generic | 109 | 22 | $2,131 |
Hospital affiliations
Frequently asked questions
What is Dr. Cayla Mays's medical specialty?
Dr. Cayla Mays practices Nurse Practitioner in Muncie, IN.
Where does Dr. Cayla Mays practice?
Dr. Cayla Mays practices at 1107 S Tillotson Ave, Muncie, IN 473044517. Office phone: 7657175399.
What is Dr. Cayla Mays's NPI?
Dr. Cayla Mays's National Provider Identifier (NPI) is 1255099503, issued by NPPES.
Does Dr. Cayla Mays accept Medicare assignment?
Yes. Dr. Cayla Mays accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Cayla Mays commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.